Scenic Biotech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $31.4M

  • Investors
  • 8

Scenic Biotech General Information

Description

Developer of a genomics and immunotherapy technology designed to assist in developing disease-modifying therapeutics for rare genetic disorders and other illnesses. The company's technology is focused on identifying modifiers that act to suppress or completely block the effect of a disease-causing mutated gene, for drug intervention, enabling scientists to rapidly identify and validate novel drug targets and then focus on developing medicines to impact the lives of patients.

Contact Information

Website
www.scenicbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Science Park 301
  • 1098 XH Amsterdam
  • Netherlands
+31 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Clinics/Outpatient Services
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Science Park 301
  • 1098 XH Amsterdam
  • Netherlands
+31 020

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scenic Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 10-Mar-2022 $31.4M Completed Pre-Clinical Trials
3. Grant 23-Jun-2020 Completed Startup
2. Early Stage VC (Series A) 24-May-2017 $7.81M $7.81M Completed Startup
1. University Spin-Out 01-Jan-2017 Completed Stealth
To view Scenic Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Scenic Biotech Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Scenic Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4419674-A1 Abhd18 inhibitors Pending 22-Oct-2021
US-20220087981-A1 Treating pathological conditions by direct and indirect targeting of sirpa-cd47 interaction Inactive 24-Jul-2017
US-20190365717-A1 Treating pathological conditions by direct and indirect targeting of sirpa-cd47 interaction Inactive 24-Jul-2017 A61P31/00

Scenic Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scenic Biotech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioMedPartners Venture Capital Minority
Eir Ventures Venture Capital Minority
Vesalius Biocapital Partners Venture Capital Minority
Netherlands Enterprise Agency Government Minority
BioGeneration Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Scenic Biotech FAQs

  • When was Scenic Biotech founded?

    Scenic Biotech was founded in 2017.

  • Where is Scenic Biotech headquartered?

    Scenic Biotech is headquartered in Amsterdam, Netherlands.

  • What is the size of Scenic Biotech?

    Scenic Biotech has 42 total employees.

  • What industry is Scenic Biotech in?

    Scenic Biotech’s primary industry is Drug Discovery.

  • Is Scenic Biotech a private or public company?

    Scenic Biotech is a Private company.

  • What is Scenic Biotech’s current revenue?

    The current revenue for Scenic Biotech is .

  • How much funding has Scenic Biotech raised over time?

    Scenic Biotech has raised $39.2M.

  • Who are Scenic Biotech’s investors?

    BioMedPartners, Eir Ventures, Vesalius Biocapital Partners, Netherlands Enterprise Agency, and BioGeneration Ventures are 5 of 8 investors who have invested in Scenic Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »